Literature DB >> 33429819

Clinicopathologic features and clinical outcomes of intravenous leiomyomatosis of the uterus: A case series.

Xiuzhang Yu1,2, Jing Fu1,2, Ting Cao1,2, Liyan Huang3, Mingrong Qie1,2, Yunwei Ouyang1,2.   

Abstract

RATIONALE: Intravenous leiomyomatosis (IVL) is a rare and special type of smooth muscle tumor originating in the uterus. It is classified as a benign disease according to its histological features but shows the behavioral characteristics of a malignant tumor. It is easily misdiagnosed and recurrent. The purpose of this study was to retrospectively analyze clinicopathological data of 25 cases of IVL in order to enhance clinicians' understanding of this rare disease. PATIENT CONCERNS: We screened and identified 25 cases of IVL at our hospital from October 2013 to January 2020. Five patients had tumors. DIAGNOSES: The diagnosis in each case was pathologically confirmed after surgical treatment.
INTERVENTIONS: All patients were managed surgically. Although the surgical procedures were different, the surgical approach was geared towards achieving complete excision. Three patients received hormonal therapy with gonadotropinreleasing hormone agonists after surgery. OUTCOMES: We retrospectively reviewed all medical records and analyzed the clinicopathologic features and clinical outcomes of this disease as well as the correlations between the clinical features and risk of recurrence. Neither the symptoms nor the preoperative imaging results were suggestive of IVL in any of the cases. Except for two patients who were lost to follow-up, twenty-three patients who were followed up are still alive. Three patients experienced a recurrence. LESSONS: The clinical manifestations and ultrasound images of IVL in the early stages are not typical; thus, IVL is easily misdiagnosed as uterine leiomyoma. Radiologists, pathologists, and surgeons should have a thorough understanding of IVL and a high index of vigilance for IVL in clinical practice. Surgery should always be aimed at achieving complete tumor excision. Patients with large lesions (≥7 cm) and lesions extending to the broad ligament may have an increased risk of recurrence. Early detection, diagnosis, and treatment are very important; once the diagnosis is confirmed, regular follow-ups are crucial.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33429819      PMCID: PMC7793403          DOI: 10.1097/MD.0000000000024228

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  3 in total

1.  Management and prognosis comparison between incidental and nonincidental intravenous leiomyomatosis: a retrospective single-center real-life experience.

Authors:  Peipei Shi; Hongyang Xiao; Hua Li; Wenbin Tang; Aimin Ren; Li Ma; Ruiqin Tu; Sheng Yin; Jiarong Zhang
Journal:  Ann Transl Med       Date:  2022-05

2.  Surgery Treatment of Primary Tumors of the Inferior Vena Cava.

Authors:  Shizhi Wang; Yuqiu Li; Qijun Yang; Xue Zhang; Yunqi Cheng; Zimeng Li; Jingyi Wang; Qingfu Zeng
Journal:  Front Med (Lausanne)       Date:  2022-03-02

3.  Identification of Novel Serum Metabolic Biomarkers as Indicators in the Progression of Intravenous Leiomyomatosis: A High Performance Liquid Chromatography-Tandem Mass Spectrometry-Based Study.

Authors:  Zhitong Ge; Penghui Feng; Zijuan Zhang; Jianchu Li; Qi Yu
Journal:  Front Cell Dev Biol       Date:  2021-07-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.